New Technology Impex

New Technology Impex LLC (შპს ნიუ ტექნოლოჯი იმპექსი) is a medical face-mask plant built in 2020 for the COVID-19 demand. It was opened on the premises of the Technical University's technical training centre with TBC Bank financing, on a project cost reported at USD 1.8m, running two production lines rated at 12 million masks a month at full capacity and staffed at 20 people with a stated plan to reach 50. Its product was branded Faceguard, made from melt-blown material. The previous text on this record was the sentence "გაიწევა მხოლოდ ძირითადი საქმიანობის საჭიროების ფარგლებში", a fragment of an accounting-policy note that had been captured as a business description; it said nothing about the company. Held 90% by Davit Miminoshvili, who is also director, and 10% by the state Partnership Fund. Files the Category III simplified form. It filed for FY2020 to FY2022 and stopped: FY2022 revenue is ₾0.22m at a 61.7% gross margin, with EBITDA of ₾-0.46m and a net loss of ₾-0.73m on ₾0.28m of total assets. The shape is a pandemic capacity build that did not outlive the demand. The Medical Devices — Production bucket is correct for what it was built to make, but nothing here is evidence that it still operates.